Form 4: Stryker CDIO Debra King Granted 6,553 RSUs
Insider Transaction Report
Stryker's VP, Chief Digital and Information Officer, Debra King, was granted 6,553 Restricted Stock Units as part of the company's long-term incentive plan.
Summary
- Debra King, Stryker's VP, Chief Digital and Information Officer, received a grant of 6,553 Restricted Stock Units (RSUs).
- The RSUs were granted on August 5, 2025, under the Stryker 2011 Long-Term Incentive Plan.
- These RSUs will vest in three equal annual installments: one-third on August 1, 2026, one-third on August 1, 2027, and the final one-third on August 1, 2028.
- Each RSU represents a contingent right to receive one share of Stryker Common Stock.
Sentiment
Score: 6
Explanation: The filing reports a routine grant of Restricted Stock Units to a key executive, which is a positive for executive retention and alignment of interests with shareholders, but does not reflect operational performance.
Positives
- The grant of Restricted Stock Units to a key executive like Debra King aligns her interests with long-term shareholder value creation.
- The multi-year vesting schedule acts as a retention mechanism for a senior officer.
Future Outlook
The RSUs are scheduled to vest in three equal tranches on August 1, 2026, August 1, 2027, and August 1, 2028, indicating a long-term incentive structure for the executive.
Industry Context
The grant of Restricted Stock Units is a common practice in the healthcare technology and medical device industry for executive compensation, aiming to align management incentives with long-term company performance and shareholder interests.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) with multi-year vesting is a standard compensation practice across large-cap medical technology companies, similar to peers like Medtronic (MDT), Johnson & Johnson (JNJ), and Abbott Laboratories (ABT), which also utilize equity awards to incentivize and retain key executives.
Related Party Transactions
- Grant of Restricted Stock Units to a senior executive as part of an approved long-term incentive plan.
Stakeholder Impact
- Shareholders: Aligns executive incentives with long-term shareholder value.
- Employees: Demonstrates commitment to retaining key leadership, potentially boosting morale.
Next Steps
- First RSU tranche vests on August 1, 2026.
- Second RSU tranche vests on August 1, 2027.
- Final RSU tranche vests on August 1, 2028.
Key Dates
| Date | Description |
|---|---|
| 08/05/2025 | Date of RSU grant to Debra King. |
| 08/07/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
| 08/01/2026 | First vesting date for one-third of the granted RSUs. |
| 08/01/2027 | Second vesting date for one-third of the granted RSUs. |
| 08/01/2028 | Final vesting date for the remaining one-third of the granted RSUs. |
Recommendation
holdThis Form 4 reports a routine grant of Restricted Stock Units to a key executive, which is a standard component of executive compensation designed to align interests with long-term shareholder value. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation based solely on this filing.
Keywords
Stryker, SYK, Restricted Stock Units, RSU, insider transaction, executive compensation, long-term incentive plan, Debra King
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.